Citation Impact

Citing Papers

Identification of Ubiquitin Ligases Required for Skeletal Muscle Atrophy
2001 StandoutScience
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
Redox mechanisms in hepatic chronic wound healing and fibrogenesis
2008
Leptin represses matrix metalloproteinase-1 gene expression in LX2 human hepatic stellate cells
2006
Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways
2001 Standout
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells
2003
Commitment of bone marrow cells to hepatic stellate cells in mouse
2003
Regulation of hepatic stellate cell proliferation and collagen synthesis by proteinase-activated receptors
2002
Thiazolidinediones
2004 Standout
CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells
1999
Pathobiology of hepatic stellate cells
1999
Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy
2004 Standout
Idiopathic pulmonary fibrosis
2017 Standout
Improved nonalcoholic steatohepatitis after 48 weeks of treatment with the PPAR-γ ligand rosiglitazone
2003
Involvement of the serine/threonine p70S6 kinase in TGF-β1-induced ADAM12 expression in cultured human hepatic stellate cells
2005
Disruption of transforming growth factor-β signaling by curcumin induces gene expression of peroxisome proliferator-activated receptor-γ in rat hepatic stellate cells
2006
Role of Obesity and Lipotoxicity in the Development of Nonalcoholic Steatohepatitis: Pathophysiology and Clinical Implications
2012
Efficacy and Safety of Aldafermin, an Engineered FGF19 Analog, in a Randomized, Double-Blind, Placebo-Controlled Trial of Patients With Nonalcoholic Steatohepatitis
2020
Selective Na+/H+ exchange inhibition by cariporide reduces liver fibrosis in the rat
2003
PDGF and signal transduction in hepatic stellate cells
2002
Liver fibrosis
2005 Standout
Association of differentially expressed genes with activation of mouse hepatic stellate cells by high-density cDNA mircoarray
2004
The Global Impact of Hepatic Fibrosis and End-Stage Liver Disease
2008
Superoxide-induced apoptosis of activated rat hepatic stellate cells
2004
Oxidative stress-related molecules and liver fibrosis
2001
Mechanisms of liver fibrosis
2005
Modulation of Hepatic Fibrosis by c-Jun-N-Terminal Kinase Inhibition
2009
NOX in liver fibrosis
2007
Steatosis: Co-factor in Other Liver Diseases *
2005
Glucagon‐like peptide‐1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high‐fat diet in nonalcoholic steatohepatitis
2011
Liver fibrosis – from bench to bedside
2003 Standout
Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome
2013 StandoutNature
Peroxisome proliferator-activated receptor-β signaling contributes to enhanced proliferation of hepatic stellate cells
2003
Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-β-dependent hepatic stellate cell activation
2006
PI-3 K/AKT and ERK signaling pathways mediate leptin-induced inhibition of PPARγ gene expression in primary rat hepatic stellate cells
2009
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
The metabolic syndrome
2010 Standout
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
2002 Standout
NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis
2003
STEATOSIS IN CHRONIC HEPATITIS C: WHY DOES IT REALLY MATTER?
2005
Hepatocellular carcinoma
2012 Standout
Adipogenic Transcriptional Regulation of Hepatic Stellate Cells
2004
Transcriptional Profiling Reveals Novel Markers of Liver Fibrogenesis
2006
Effects of extracellular matrix viscoelasticity on cellular behaviour
2020 StandoutNature
Effect of adipose tissue insulin resistance on metabolic parameters and liver histology in obese patients with nonalcoholic fatty liver disease
2011
Non-alcoholic fatty liver disease: The mist gradually clears
2008
Oxidative stress decreases pHi and Na+/H+ exchange and increases excitability of solitary complex neurons from rat brain slices
2004 StandoutNobel
Peroxisome proliferator-activated receptor γ transcriptional regulation is involved in platelet-derived growth factor-induced proliferation of human hepatic stellate cells
2000
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Pharmacological agents for NASH
2013
Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial
2008
Hypoxia and the extracellular matrix: drivers of tumour metastasis
2014 StandoutNobel
Regulation of PDGF and its receptors in fibrotic diseases
2004
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
mTOR Signaling in Growth, Metabolism, and Disease
2017 Standout
The metabolic syndrome
2005 Standout
Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis
2006
Non-alcoholic fatty liver disease
2021 Standout
Mechanobiology of tendon
2005
Cytochrome P450 2E1-derived Reactive Oxygen Species Mediate Paracrine Stimulation of Collagen I Protein Synthesis by Hepatic Stellate Cells
2002
Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury
2000 Standout
Role of endogenous opioids in modulating HSC activity in vitro and liver fibrosis in vivo
2007
Mechanisms of Hepatic Fibrogenesis
2008 Standout
Long-Term Efficacy of Rosiglitazone in Nonalcoholic Steatohepatitis: Results of the Fatty Liver Improvement by Rosiglitazone Therapy (Flirt 2) Extension Trial
2009
Characterization of a Stellate Cell Activation-associated Protein (STAP) with Peroxidase Activity Found in Rat Hepatic Stellate Cells
2001
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
2004
Iron-induced oxidant stress in alcoholic liver fibrogenesis
2003
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
2003 Standout
Smooth Muscle α Actin (Acta2) and Myofibroblast Function during Hepatic Wound Healing
2013
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient l-amino acid-defined diet
2004
Differential expression genes analyzed by cDNA array in the regulation of rat hepatic fibrogenesis
2006
Adipogenic Phenotype of Hepatic Stellate Cells
2005
Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
2005
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial
2014 Standout
Effects of Sho–Saiko–To, A Japanese Herbal Medicine, on Hepatic Fibrosis in Rats
1999
Mechanisms of fibrosis: therapeutic translation for fibrotic disease
2012 Standout
Malondialdehyde–acetaldehyde–protein adducts increase secretion of chemokines by rat hepatic stellate cells
2001
Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels
2013 StandoutNobel
Risk of Cardiovascular Disease in Patients with Nonalcoholic Fatty Liver Disease
2010 Standout
Leptin enhances α1(I) collagen gene expression in LX-2 human hepatic stellate cells through JAK-mediated H2O2-dependent MAPK pathways
2005
Strong antiproliferative effects of baicalein in cultured rat hepatic stellate cells
1999
Single-Cell Transcriptomic Analysis of Primary and Metastatic Tumor Ecosystems in Head and Neck Cancer
2017 Standout
Signal transduction in hepatic stellate cells
1998
PPAR-γ agonist attenuates renal interstitial fibrosis and inflammation through reduction of TGF-β
2008
Effectiveness of the PPARγ agonist, GW570, in liver fibrosis
2010
Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study
2015 Standout
AKT/PKB Signaling: Navigating the Network
2017 Standout
Dose dependent and divergent effects of superoxide anion on cell death, proliferation, and migration of activated human hepatic stellate cells
2005
Idiopathic pulmonary fibrosis
2011 Standout
Tumor Necrosis Factor α-dependent Up-regulation of Lrh-1 and Mrp3(Abcc3) Reduces Liver Injury in Obstructive Cholestasis
2003
Hepatocellular carcinoma pathogenesis: from genes to environment
2006 Standout
Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function
2007
Inhibitory effect of a soluble transforming growth factor β type II receptor on the activation of rat hepatic stellate cells in primary culture
2003
Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis
2010 Standout
Enhanced carbon tetrachloride-induced liver fibrosis in mice lacking adiponectin
2003
Hepatocellular Carcinoma
2011 Standout
Antifibrotic activities of pirfenidone in animal models
2011
High glucose stimulates hepatic stellate cells to proliferate and to produce collagen through free radical production and activation of mitogen‐activated protein kinase
2005
Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver
2008 Standout
Peroxisome Proliferator-activated Receptor γ Suppresses Proximal α1(I) Collagen Promoter via Inhibition of p300-facilitated NF-I Binding to DNA in Hepatic Stellate Cells
2005
Gene Expression Profiles During Hepatic Stellate Cell Activation in Culture and In Vivo
2007
Molecular regulation of hepatic fibrogenesis
1998
Anti‐oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats
2001
Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited
2009 Standout
The Myofibroblast
2007 Standout
Extracellular signal-regulated kinase activation differentially regulates platelet-derived growth factor's actions in hepatic stellate cells, and is induced by In Vivo liver injury in the rat
1999
The potential role of genes in nonalcoholic fatty liver disease
2004
Replication of hepatitis C virus
2007 StandoutNobel
Caffeine Inhibits the Activation of Hepatic Stellate Cells Induced by Acetaldehyde via Adenosine A2A Receptor Mediated by the cAMP/PKA/SRC/ERK1/2/P38 MAPK Signal Pathway
2014
Liver Fibrogenesis: A New Role for the Renin–Angiotensin System
2005
The endocannabinoid 2‐arachidonoyl glycerol induces death of hepatic stellate cells via mitochondrial reactive oxygen species
2007
Evaluation of Liver Fibrosis: A Concise Review
2004
Adipokines and liver fibrosis.
2006
Opposing effects of oestradiol and progesterone on intracellular pathways and activation processes in the oxidative stress induced activation of cultured rat hepatic stellate cells
2005
PDGF and signal transduction in hepatic stellate cells
2002
Liver nbsp fibrosis signals leading to the amplification of the fibrogenic hepatic stellate cell
2003
Improved Nonalcoholic Steatohepatitis After 48 Weeks of Treatment With the Ppar–γ Ligand Rosiglitazone
2003
Associations Between Liver Histology and Severity of the Metabolic Syndrome in Subjects With Nonalcoholic Fatty Liver Disease
2005
Reversible Near-Infrared Fluorescent Probe Introducing Tellurium to Mimetic Glutathione Peroxidase for Monitoring the Redox Cycles between Peroxynitrite and Glutathione in Vivo
2013 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Catalytic Dehydrogenative Cross-Coupling: Forming Carbon−Carbon Bonds by Oxidizing Two Carbon−Hydrogen Bonds
2011 Standout
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
The selective cyclooxygenase‐2 inhibitor SC‐236 reduces liver fibrosis by mechanisms involving non‐parenchymal cell apoptosis and PPARγ activation
2005
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Fibrosis — A Common Pathway to Organ Injury and Failure
2015 Standout
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Anti‐adipogenic regulation underlies hepatic stellate cell transdifferentiation
2006
Establishment of an Immortalized Human Hepatic Stellate Cell Line to Develop Antifibrotic Therapies
2003
NAD(P)H oxidase plays a crucial role in PDGF‐induced proliferation of hepatic stellate cells†
2005
Increased expression of extracellular signal-regulated kinase and angiotensin-converting enzyme in human atria during atrial fibrillation
2000
An adipocentric view of liver fibrosis and cirrhosis.
2004
HEPATIC FIBROSIS: Molecular Mechanisms and Drug Targets
2004
Current status of novel antifibrotic therapies in patients with chronic liver disease
2011
Organoselenium and Organotellurium Compounds:  Toxicology and Pharmacology
2004 Standout

Works of F. Ridolfi being referenced

Rearrangement of the cytoskeletal network induced by platelet-derived growth factor in rat hepatic stellate cells: role of different intracellular signalling pathways
2002
Insulin and Insulin–Like Growth Factor–1 Stimulate Proliferation and Type I Collagen Accumulation by Human Hepatic Stellate Cells: Differential Effects on Signal Transduction Pathways
1999
Regulation of ERK/JNK/p70S6K in two rat models of liver injury and fibrosis
2003
Fibrogenic effect of oxidative stress on rat hepatic stellate cells
1998
Intracellular pH regulation and Na + /H + exchange activity in human hepatic stellate cells: effect of platelet-derived growth factor, insulin-like growth factor 1 and insulin
2001
Effect of pirfenidone on rat hepatic stellate cell proliferation and collagen production
2002
Antidiabetic thiazolidinediones inhibit collagen synthesis and hepatic stellate cell activation in vivo and in vitro
2002
Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2‐mediated mechanism†
2005
Inhibition of the Na+/H+ exchanger reduces rat hepatic stellate cell activity and liver fibrosis: An in vitro and in vivo study
2001
Bile acids induce hepatic stellate cell proliferation via activation of the epidermal growth factor receptor
2005
Intracellular pathways mediating Na+/H+ exchange activation by platelet-derived growth factor in rat hepatic stellate cells
1999
The Na+/H+ exchanger modulates the fibrogenic effect of oxidative stress in rat hepatic stellate cells
1999
Characterization of ion transport mechanisms regulating intracellular pH in hepatic stellate cells
1997
Intracellular Signaling Pathways Involved in Acetaldehyde–Induced Collagen and Fibronectin Gene Expression in Human Hepatic Stellate Cells
2001
Rankless by CCL
2026